新华制药：关于子公司获得克拉霉素干混悬剂《药品注册证书》的公告

Group 1 - The core point of the article is that Xinhua Pharmaceutical announced the approval of its subsidiary's drug registration for Clarithromycin suspension by the National Medical Products Administration [2] Group 2 - The drug registration certificate for Clarithromycin suspension has been officially issued, indicating regulatory approval for the product [2]